Hazlett, Burt & Watson’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-157
Closed -$4K 925
2026
Q1
$4K Buy
157
+2
+1% +$51 ﹤0.01% 795
2025
Q4
$4K Buy
155
+2
+1% +$51 ﹤0.01% 802
2025
Q3
$4K Buy
+153
New +$3.88K ﹤0.01% 752

Other funds holding IBDX

Hazlett, Burt & Watson's IBDX Position: Q2 2026 in Review

Hazlett, Burt & Watson sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026, closing a stake of 157 shares — an estimated $4K sold.

Hazlett, Burt & Watson first reported a position in IBDX in Q3 2025 and held it in 3 quarters. The position peaked at $4K in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Hazlett, Burt & Watson reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 157 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $4K.
  • Hazlett, Burt & Watson first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and held it in 3 quarters.
  • Hazlett, Burt & Watson's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $4K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.